Mohanram Narayanan, MD, FACP, FASN, FRCP(C)

Nephrologist
Scott & White Healthcare

Director, Division of Nephrology/Hypertension
Medical Director, Scott & White Killeen Dialysis
Chief, Section of Clinical Transplantation, Department of Medicine


Specialties
Nephrology


Patient Care Emphasis
Fluid & Electrolyte Disturbances, Glomerulonephritis, Kidney Transplantation, Pancreas Transplants, Renal Artery Stenosis, Severe or Difficult to Control Hypertension


Board Certification
  • Diplomate of the American Board of Geriatric Medicine
  • Diplomate of the American Board of Internal Medicine
  • Diplomate of the American Board of Nephrology

  • Scott & White Appointment
    August 15, 1994


    Education
  • Christian Medical College, Ludhiana, India, MBBS, 1982
  • Loyola College, Madras, India, BS, 1978

  • Specialty Training
  • Nephrology Clinical Fellowship, University of Texas Southwestern Medical Center, Dallas, TX
  • Nephrology Clinical Fellowship, University of Illinois College of Medicine, Chicago, IL
  • Internal Medicine Residency, Cook County Hospital, Chicago, IL

  • Faculty Rank - Texas A&M Health Science Center College of Medicine
    Associate Professor of Medicine


    Publications and Research
  • Narayanan M, Watson RE, DiPette DJ: Hypertension: Evaluation, Therapy & Review of Landmark Trials. In Abela GS, ed. Peripheral Vascular Disease: Basic Diagnostic & Therapeutic Approaches. Philadelphia: Lippincott, Williams & Wilkins, 105-122.
  • Narayanan M, Slavcheva E, Rao A, Jones K, Jaffers G: Renal Cell Carcinoma Following BK Virus & SV40 Co-Infection in Polyomavirus Nephropathy. Journal of the American Society of Nephrology October; 15: 869A
  • Slavcheva E, McCuskey C, Harris D, Narayanan M, Jaffers G: Outcomes of Renal Allograft Biopsy under Direct Ultrasonographic Visualization. Journal of the American Society of Nephrology October; 15: 887A
  • Improvement of Bone Density with Alendronate after Renal Transplantation 662 Elena Slavcheva, Charles McCuskey, Mohanram Narayanan, Gregory Jaffers et al 662 Abstract presented at the 3rd American Transplant Congress, May, Washington, D.C.
  • Slavcheva E, McCuskey C, Fisher M, Atkins M, Narayanan M, Jaffers G: Improvement of Bone Density with Alendronate after Renal Transplantation. American Journal of Transplantation June; Supplement 5; 3: 244A
  • Treatment of CMV Infection in Renal Transplant Recipients with an Abbreviated Course of IV Ganciclovir - Elena Slavcheva, Gregory Jaffers, Mohanram Narayanan et al 26E Abstract presented at the 35th Annual Meeting of the American Society of Nephrology, Nov., Philadelphia, PA. (SU-P0470)
  • Slavcheva E, Jaffers G, Narayanan M, Moore C, McCuskey C, Carpenter C: Treatment of CMV Infection in Renal Transplant Recipients with an Abbreviated Course of IV Ganciclovir. Journal of the American Society of Nephrology September; 13: 564A
  • Clark LJ, Kanarvogel L, Narayanan M, Runde M, Smith GA: Internal Medicine Practice Questions Book 1, Vol 1&2 Ed Burday MJ; Medtext Medical Publishing Co. Redondo Beach, CA
  • Effect of Hepatitis C infection on anemia in hemodialysis patients 772 Anand Khurana, Mohanram Narayanan, Allan E Nickel 662Abstract presented at the Spring Clinical Meeting of the National Kidney Foundation, April, Orlando, FL.
  • Statin Use Improves Survival Post Kidney Transplantation 626 Judson Severson, Luis Concepcion, Mohanram Narayanan 626 Abstract presented at the 40th Annual Meeting of the American Society of Nephrology, Nov. San Francisco, CA (SAPO443)
  • Khurana A, Runge V, Narayanan M, Greene Jr. J, Nickel A: Nephrogenic Systemic Fibrosis: A Review of Six Cases Temporally Related to Gadodiamide Injection (Omniscan). Investigative Radiology Feb.; 42 (2): 139-145
  • Narayanan M, Szymanski J, Slavcheva E, Rao A, Kelly A, Jones K, Jaffers G: BK Virus Associated Renal Cell Carcinoma: Case Presentation with Optimized PCR and Other Diagnostic Tests. American Journal of Transplantation; 7 (6): 1666-1671
  • Severson J, Concepcion L, Narayanan, M: Statin Use Improves Survival Post Kidney Transplantation. Journal of the American Society of Nephrology October; 18: 438A
  • Severson J, Concepcion L, Narayanan, M: Risk factors for BK Virus Infection. Journal of the American Society of Nephrology October; 18: 884A
  • Post transplant anemia: A single center experience 626 Anand Khurana, Mohanram Narayanan 66E Abstract presented at the Annual Meeting of the Texas Transplantation Society, July, San Antonio, TX.
  • Retrospective Evaluation and Characterization of Health Care Utilization in a Managed Care Organization for Members with Stage 1, 2, or 3 Chronic Kidney Disease 66E Tonya Martin, Charles Foulks, Barry Browne, Mohanram Narayanan 626 Abstract presented at the 39th Annual Meeting of the American Society of Nephrology, Nov. San Diego, CA (SA-PO337)
  • Martin T, Foulks C, Browne B, Narayanan, M: Retrospective Evaluation and Characterization of Health Care Utilization in a Managed Care Organization for Members with Stage 1, 2, or 3 Chronic Kidney Disease. Journal of the American Society of Nephrology November; 17: 646A
  • Khurana A, Foulks, C, Narayanan, M: Post Transplant Anemia: A Single Center Experience. Journal of the American Society of Nephrology November; 17: 860A
  • Incidence & Risk Factors for Development of Post Transplant Diabetes Mellitus in Renal Allograft Recipients 727 a single center experience 662 Nidhi Munshi, Mohanram Narayanan - Poster and Podium presentation at 99th Annual Scientific Assembly of Southern Medical Association, Nov, San Antonio, TX.
  • Munshi N, Narayanan M: Incidence and Risk Factors for Development of Post Transplant Diabetes Mellitus in Renal Allograft Recipients: A Single-Center Experience. Southern Medical Journal October; 98(10): S64
  • Alberto G, Erickson T, Popiel R, Narayanan M, Hryhorczuk D: Central Nervous System Manifestations of a Valproic Acid Overdose Responsive to Naloxone. Annals of Emergency Medicine; 18 (8):889-891
  • Martin TM, Browne BA, Foulks CJ, Narayanan M, Powell K. Health care utilization in a managed care setting for members with Stage 1, 2 or 3 chronic kidney disease
  • Primary Hyperoxaluria Causing ESRD and Lower Extremity Gangrene 662 Nidhi Munshi, Mohanram Narayanan 66E Abstract and Poster presented at the Annual Dialysis Conference March, Orlando, FL.
  • Khurana A, Nickel A, Narayanan M, Foulks C: Effect of Hepatitis C Infection on Anemia in Hemodialysis Patients. Hemodialysis International; 12 (1): 94-99
  • Munshi N, Concepcion L, Narayanan M: Primary Hyperoxaluria Causing ESRD and Lower Extremity Gangrene. Hemodialysis International; 12 (2): 149
  • Khurana A, Nickel A, Greene Jr. J, Narayanan M, High W, Foulks C: Successful Pregnancy in a Hemodialysis Patient and Marked Resolution of Her Nephrogenic Systemic Fibrosis. American Journal of Kidney Disease; 51 (6): e29-e32
  • Mahajan A, Narayanan M, Song J: Determinants of Immune Function in Renal Transplant Patients. Journal of the American Society of Nephrology, Oct 2008;19:446A
  • Mahajan A, Concepcion L, Narayanan M: Elemental My Dear Watson. Journal of the American Society of Nephrology, Oct 2008;19:939A
  • Munshi N, Concepcion L, Narayanan M: Primary Hyperoxaluria Causing ESRD and Gangrene of Extremities Leading to Amputations. Hemodialysis International 2009;13(3):266-270
  • Goraya N, Narayanan M, Jaffers G: Biopsy Proven BK Polyoma Nephropathy in the Presence of Viruria and Lack of Viremia. American Journal of Transplantation. May 2009;Supp 2;9:426
  • Irish W, Greenstein S, Doria C, Chan L, Narayanan M, et al: The Mycophenologic Acid Observational Renal Transplant Study (MORE) Registry: Summary of Patient Management in De Novo Renal Transplantation. Amer Journal of Transplantation, May 2009;Supp 2;9:502
  • Mahajan A, Narayanan M, Concepcion L, Jaffers G: Hypoparathyroidism Associated with Severe Mineral Bone Disease Post Renal Transplantation, Treated Successfully with Recombinant PTH. Hemodialysis International 2009;13(4):547-550
  • Irish W, Doria C, Greenstein S, Chan L, Narayanan M, et al: Mycophenolic Acid (MPA) Therapy in Kidney Transplantation: An Analysis of the MORE Registry. Journal of the Amer Society of Nephrology Oct 2009;20:573A
  • Irish W, Doria C, Greenstein S, Chan L, Narayanan M, et al. Mycophenolic Acid (MPA) in Diabetic Kidney Transplant Patients: An Analysis of the MORE Registry. Journal of the Amer Soc of Nephrology, Oct 2009;20:885A-886A
  • Mahajan A, Narayanan M, Jaffers G: Atypical Presentation of Cytomegalovirus Colitis in Renal Allograft Recipients. Journal of the Amer Soc of Nephrology Oct 2009;20:897A-898A
  • Chan L, Irish W, Doria C, Greenstein S, Narayanan M, et al: Distinct Effects of Delayed Graft Function (DGF) and Acute Rejection (BPAR) on Graft Failure (GF) following Kidney Transplantation (KTx): Analysis of the Mycophenolic Acid (MPA) Observational Renal Transplant (MORE) Registry. Amer J of Transplantation May 2010;Supp 4;10:168
  • Irish W, Doria C, Greenstein S, Chan L, Narayanan M, et al: Durable Dosing Patterns of Mycophenolic Acid (MPA) in Renal Transplantation: Initial Outcome Analysis of the Mycophenolic Acid (MPA) Observational Renal Transplant (MORE) Registry. Amer J of Transplantation May 2010;Supp 4;10:170-171
  • Langone A, Irish W, Doria C, Greenstein S, Narayanan M, et al: Real-World Calcineurin Inhibitor (CNI) Minimization Strategies: Outcomes Analysis of the Mycophenolic Acid (MPA) Renal Transplant (MORE) Registry. Amer J of Transplantation May 2010;Supp 4;10:509
  • Narayanan M, Pankewycz O, et al: Enteric-Coated Mycophenolate Sodium (EC-MPS) Versus Mycophenolate Mofetil (MMF) in African American (AA) Renal Transplant Recipients from the Mycophenolic Acid Observational Renal Transplant (MORE) Registry. J of Amer Society of Nephrology Nov 2010;21:325A
  • Goraya N, Narayanan M: Prediction of Cardiovascular Disease during Pre-Transplant Evaluation. J of Amer Society of Nephrology, Nov 2010;21:329A
  • Shihab F, Chan L, Narayanan M, et al: Comparisons of Enteric-Coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Recipients (RTRS) with Diabetes Mellitus (DM) prior to Transplant in the Mycophenolic Acid Observational Renal Transplant (MORE) Registry. J of Amer Society of Nephrology, Nov 2010;21:969A
  • Narayanan M, Pankewycz O, et al: Enteric-Coated Mycophenolate Sodium (EC-MPS) versus Mycophenolate Mofetil (MMF) in African American (AA) Renal Transplant Recipients from the Mycophenolic Acid Observational Renal Transplant (MORE) Registry. Amer J of Transplantation Apr 2011;Supp 2;11:316-317
  • Shihab F, Chan L, Narayanan M, et al: Early Outcome Analysis of the Mycophenolic Acid Observational Renal Transplant (MORE) Registry: Comparisons of Enteric-Coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Patients with Diabetes Mellitus (DM) prior to Transplant. Amer J of Transplantation Apr 2011;Supp 2;11:319


  • Awards and Honors
  • Fellow, American Society of Nephrology
  • Fellow, American College of Physicians
  • Fellow, Royal College of Physicians and Surgeons of Canada

  • Professional Memberships
  • Medical Review Board, ESRD Network, State of Texas
  • Kidney Councilor, Texas Transplantation Society

  • Languages Spoken
    English, Hindi, Malayalam, Punjabi, Tamil


    Locations


    Scott & White Clinic & Dialysis Center - Temple South Loop
    2601 Thornton Lane
    Temple, TX 76502
    254-935-5853
    Scott & White Dialysis Center - Killeen
    3701 Scott & White Drive
    Killeen, TX 76543
    254-680-1371
    Scott & White Dialysis Center - Killeen West
    2201 South W.S. Young Drive
    Suite 101B
    Killeen, TX 76543
    254-501-6467
    Temple Dialysis Center
    2601 Thornton Lane
    Temple, TX 76502
    254-935-5888

    Appointments